Steven P. Gelone Nabriva Therapeutics PLC (NBRV) insider trading activity

Steven P. Gelone is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 14,283 shares of NBRV, which is worth approximately $5,713. The most recent transaction as insider was on Jan 29, 2023, when has been sold 140 shares (Ordinary Shares) at a price of $1.5 per share, resulting in proceeds of $210. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K

0% 3M change

0% 12M change

Total Value Held $5,713

Steven P. Gelone Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2023	SELL Payment of exercise price or tax liability	$210 $1.5 p/Share	140 Reduced 0.97%	14,283 Ordinary Shares
Jan 06 2023	SELL Payment of exercise price or tax liability	$6 $1.3 p/Share	5 Reduced 0.03%	14,423 Ordinary Shares
Dec 31 2022	SELL Payment of exercise price or tax liability	$5 $1.89 p/Share	3 Reduced 0.02%	14,428 Ordinary Shares
Dec 06 2022	SELL Payment of exercise price or tax liability	$8 $2.02 p/Share	4 Reduced 0.03%	14,431 Ordinary Shares
Nov 30 2022	SELL Payment of exercise price or tax liability	$6 $2.25 p/Share	3 Reduced 0.02%	14,435 Ordinary Shares
Nov 06 2022	SELL Payment of exercise price or tax liability	$8 $2.24 p/Share	4 Reduced 0.03%	14,438 Ordinary Shares
Oct 31 2022	SELL Payment of exercise price or tax liability	$7 $2.54 p/Share	3 Reduced 0.02%	14,442 Ordinary Shares
Oct 06 2022	SELL Payment of exercise price or tax liability	$11 $2.72 p/Share	4 Reduced 0.03%	14,445 Ordinary Shares
Sep 30 2022	SELL Payment of exercise price or tax liability	$6 $2.08 p/Share	3 Reduced 0.02%	14,449 Ordinary Shares
Sep 06 2022	SELL Payment of exercise price or tax liability	$14 $0.16 p/Share	89 Reduced 0.02%	361,311 Ordinary Shares
Aug 31 2022	SELL Payment of exercise price or tax liability	$10 $0.16 p/Share	61 Reduced 0.02%	361,400 Ordinary Shares
Aug 06 2022	SELL Payment of exercise price or tax liability	$16 $0.18 p/Share	89 Reduced 0.02%	361,461 Ordinary Shares
Jul 31 2022	SELL Payment of exercise price or tax liability	$11 $0.18 p/Share	61 Reduced 0.02%	361,550 Ordinary Shares
Jul 06 2022	SELL Payment of exercise price or tax liability	$16 $0.18 p/Share	89 Reduced 0.02%	361,611 Ordinary Shares
Jun 30 2022	SELL Payment of exercise price or tax liability	$11 $0.18 p/Share	61 Reduced 0.02%	361,700 Ordinary Shares
Jun 06 2022	SELL Payment of exercise price or tax liability	$18 $0.2 p/Share	89 Reduced 0.02%	361,761 Ordinary Shares
May 31 2022	SELL Payment of exercise price or tax liability	$13 $0.21 p/Share	61 Reduced 0.02%	361,850 Ordinary Shares
May 06 2022	SELL Payment of exercise price or tax liability	$23 $0.26 p/Share	89 Reduced 0.02%	361,911 Ordinary Shares
Apr 30 2022	SELL Payment of exercise price or tax liability	$19 $0.31 p/Share	61 Reduced 0.02%	362,000 Ordinary Shares
Apr 06 2022	SELL Payment of exercise price or tax liability	$36 $0.41 p/Share	89 Reduced 0.02%	362,061 Ordinary Shares
Mar 31 2022	SELL Payment of exercise price or tax liability	$26 $0.42 p/Share	61 Reduced 0.02%	362,150 Ordinary Shares
Mar 06 2022	SELL Payment of exercise price or tax liability	$38 $0.43 p/Share	89 Reduced 0.02%	362,211 Ordinary Shares
Feb 28 2022	SELL Payment of exercise price or tax liability	$27 $0.45 p/Share	61 Reduced 0.02%	362,300 Ordinary Shares
Feb 06 2022	SELL Payment of exercise price or tax liability	$51 $0.48 p/Share	106 Reduced 0.03%	362,361 Ordinary Shares
Jan 31 2022	SELL Payment of exercise price or tax liability	$35 $0.48 p/Share	73 Reduced 0.02%	362,467 Ordinary Shares

SPG

Steven P. Gelone

Director

Fort Washington, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Value

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nabriva Therapeutics plc

Track Activities on NBRV

Account